SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

JB Chemicals’ export to Russia-CIS market up 23% in Q3FY19

08 Feb 2019 Evaluate

JB Chemicals & Pharmaceuticals has reported growth of 22.60% in its export to Russia-CIS market during third quarter of fiscal year 2018-19 (Q3FY19). The company has recently received a new product registration for Pantoprazole 20 mg in Russia and expects to launch the product in Q1 next year. Besides, The year-to-date (April-December) growth of the company in the market stood at 33.80%.

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

2151.90 10.55 (0.49%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×